Type 1 Diabetes Trial, Recruiting (NCT07286500)

Type 1 Diabetes Trial, Recruiting NCT07286500 Sponsor: Medical University of Warsaw Condition: Type 1 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT07286500 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 1 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 years or older
People who have been diagnosed with type 1 or type 2 diabetes
People who are currently using a continuous glucose monitoring (CGM) system, which is a device that tracks blood sugar levels throughout the day
People who are being treated with insulin, in any form or schedule
People who are able to use the CGM app on their own and can mark when sexual activity begins within the app
People who are willing to take part in the trial for 3 months
People who have signed a consent form agreeing to participate

Who may not be able to join:

People who are unable to use the CGM app independently, without help from others
People who do not expect to have any sexual activity during the 3-month study period
People who withdraw their consent to participate at any point during the trial
People who have any health condition that, in the opinion of the doctor running the trial, would make it unsafe for them to take part (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +48 22 599 2583

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07286500

Sponsor: Medical University of Warsaw

Phase: Not Applicable

Status: Recruiting

Condition: Type 1 Diabetes

Trial contact: +48 22 599 2583

More information: https://clinicaltrials.gov/study/NCT07286500

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 years or older
People who have been diagnosed with type 1 or type 2 diabetes
People who are currently using a continuous glucose monitoring (CGM) system, which is a device that tracks blood sugar levels throughout the day
People who are being treated with insulin, in any form or schedule
People who are able to use the CGM app on their own and can mark when sexual activity begins within the app
People who are willing to take part in the trial for 3 months
People who have signed a consent form agreeing to participate

Who may not be able to join:

People who are unable to use the CGM app independently, without help from others
People who do not expect to have any sexual activity during the 3-month study period
People who withdraw their consent to participate at any point during the trial
People who have any health condition that, in the opinion of the doctor running the trial, would make it unsafe for them to take part (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Medical University of Warsaw

Registry

ClinicalTrials.gov

Start date

30 July 2025

Est. completion

1 July 2028

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

Proportion of Sexual Activity Episodes Associated With Hypoglycemia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov